SecBot SecBot
SECBOTREPLAY Home › Report › PHIO

PHIO · Phio Pharmaceuticals Corp

Phio Pharmaceuticals Corp. · DEFA14A filed Aug 14, 2026 at 16:10 ET

At the news

NEUTRALIMPACT 3/10

DEFA14A filed Aug 14, 2026 at 16:10 ET

Phio Pharmaceuticals Corp. filed a DEFA14A (additional definitive proxy soliciting materials) for its 2026 Annual Meeting of Stockholders to be held on September 28, 2026. The filing is a routine notice providing instructions for accessing proxy materials and voting online, with the Board recommending votes FOR all six director nominees, ratification of Grant Thornton as auditor, and approval of a 1,500,000 share increase to the 2020 Long Term Incentive Plan. No financial results, activist activity, or material corporate events are disclosed.

  • Annual Meeting scheduled for September 28, 2026, held virtually.
  • Record date for voting is August 4, 2026.
  • Board recommends FOR election of six director nominees: Robert J. Bitterman, Patricia A. Bradford, David H. Deming, Jonathan E. Freeman, Curtis A. Lockshin, and R. Todd Plott.
  • Board recommends FOR ratification of Grant Thornton, LLP as independent auditor for FY 2026.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access